Clinical Trials
3 trialsNCT02988843 2020-12-10
Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT01966913 2019-02-19
TAXIFIII
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Unknown
NCT00393861 2016-03-24
Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients
Indiana University
Phase 2 Completed